A alpha-glycerophosphoric acid, (DL)-isomer CEP of the European Pharmacopoeia monograph is often referred to as a alpha-glycerophosphoric acid, (DL)-isomer Certificate of Suitability (COS). The purpose of a alpha-glycerophosphoric acid, (DL)-isomer CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of alpha-glycerophosphoric acid, (DL)-isomer EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of alpha-glycerophosphoric acid, (DL)-isomer to their clients by showing that a alpha-glycerophosphoric acid, (DL)-isomer CEP has been issued for it. The manufacturer submits a alpha-glycerophosphoric acid, (DL)-isomer CEP (COS) as part of the market authorization procedure, and it takes on the role of a alpha-glycerophosphoric acid, (DL)-isomer CEP holder for the record. Additionally, the data presented in the alpha-glycerophosphoric acid, (DL)-isomer CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the alpha-glycerophosphoric acid, (DL)-isomer DMF.
A alpha-glycerophosphoric acid, (DL)-isomer CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. alpha-glycerophosphoric acid, (DL)-isomer CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of alpha-glycerophosphoric acid, (DL)-isomer suppliers with CEP (COS) on PharmaCompass.